598
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression

, ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 2839-2853 | Received 27 Dec 2022, Accepted 02 May 2023, Published online: 30 May 2023

References

  • Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–958. doi:10.1001/jama.2015.0954
  • Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016;2:16014. doi:10.1038/nrdp.2016.14
  • Singh P, Staller K, Barshop K, et al. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World j Gastroenterol. 2015;21(26):8103–8109. doi:10.3748/wjg.v21.i26.8103
  • Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. lancet Gastroenterol Hepatol. 2019;4(8):632–642. doi:10.1016/S2468-1253(19)30089-5
  • Shi C, Dawulieti J, Shi F, et al. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci Adv. 2022;8(4):eabj2372.
  • Barbaro MR, Cremon C. Non-Celiac Gluten Sensitivity in the Context of Functional Gastrointestinal Disorders. Nutrients. 2020;12(12):3735. doi:10.3390/nu12123735
  • Martin CR, Osadchiy V, Kalani A, Mayer EA. The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–148. doi:10.1016/j.jcmgh.2018.04.003
  • Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: a Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017;153(2):448–459. doi:10.1053/j.gastro.2017.05.003
  • Xu J, Xu J, Shi T, et al. Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome. Adv Mater. 2023;35(3):e2207890. doi:10.1002/adma.202207890
  • Zhang W, Xu JH, Yu T, Chen QK. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Biomed Pharmacother. 2019;118:109131. doi:10.1016/j.biopha.2019.109131
  • Lu Y, Huang J, Zhang Y, et al. Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Front Pharmacol. 2021;12:596686. doi:10.3389/fphar.2021.596686
  • Wang Y, Tong Q, Ma SR, et al. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota. Signal Transduction and Targeted Therapy. 2021;6(1):77. doi:10.1038/s41392-020-00456-5
  • Qu D, Wang L, Qin Y, et al. Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion. Biomaterials sci. 2018;6(12):3284–3299. doi:10.1039/C8BM00796A
  • Su X, Gao C, Shi F, et al. A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance. Drug Deliv. 2017;24(1):10–19. doi:10.1080/10717544.2016.1225854
  • Gui SY, Wu L, Peng DY, Liu QY, Yin BP, Shen JZ. Preparation and evaluation of a microemulsion for oral delivery of berberine. Die Pharmazie. 2008;63(7):516–519.
  • Ang QY, Alexander M, Newman JC, et al. Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells. Cell. 2020;181(6):1263–1275. doi:10.1016/j.cell.2020.04.027
  • Gigante I, Tutino V, Russo F. Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet. International Journal of Molecular Sciences. 2021;22(6):2880. doi:10.3390/ijms22062880
  • Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790–4805. doi:10.1111/bph.13250
  • Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199–215. doi:10.1038/sj.bjp.0707442
  • Fathalipour S, Ataei B, Janati F. Aqueous suspension of biocompatible reduced graphene oxide- Au NPs composite as an effective recyclable catalyst in a Betti reaction. Mater Sci Eng C Mater Biol Appl. 2019;97:356–366. doi:10.1016/j.msec.2018.12.048
  • Zhong L, Xu L, Liu Y, et al. Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy. Acta pharmaceutica Sinica B. 2019;9(2):397–409. doi:10.1016/j.apsb.2018.11.006
  • Zuo Z, Li M, Han T, et al. A platelet-cloaking tetramethylprazine-loaded microemulsion for improved therapy of myocardial ischaemia/reperfusion injury. J Drug Target. 2022;30(6):646–656. doi:10.1080/1061186X.2022.2048389
  • Chen Y, Wang S, Hu Q, Zhou L. Self-Emulsifying System Coloaded with Paclitaxel and Coix Seed Oil Deeply Penetrated to Enhance Efficacy of Cervical Cancer. Curr Drug Deliv. 2022;2:56.
  • Maulvi FA, Desai AR, Choksi HH, et al. Effect of surfactant chain length on drug release kinetics from microemulsion-laden contact lenses. Int J Pharm. 2017;524(1–2):193–204. doi:10.1016/j.ijpharm.2017.03.083
  • Bao CH, Wang CY, Li GN, et al. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome. World j Gastroenterol. 2019;25(32):4696–4714. doi:10.3748/wjg.v25.i32.4696
  • Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology. 2000;119(5):1276–1285. doi:10.1053/gast.2000.19576
  • Zhou Q, Verne ML, Fields JZ, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019;68(6):996–1002. doi:10.1136/gutjnl-2017-315136
  • Pleguezuelos-Manzano C, Puschhof J, van den Brink S, Geurts V, Beumer J, Clevers H. Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells. Curr Protocols Immunol. 2020;130(1):e106. doi:10.1002/cpim.106
  • Mohammadi S, Morell-Perez C, Wright CW, et al. Assessing donor-to-donor variability in human intestinal organoid cultures. Stem Cell Reports. 2021;16(9):2364–2378. doi:10.1016/j.stemcr.2021.07.016
  • Lin J, Huang L, Xiang R, et al. Blood compatibility evaluations of CaCO 3 particles. Biomed Mater. 2021;16(5):055010. doi:10.1088/1748-605X/ac19bf
  • Mohamed AS, Fahmy SR, Soliman AM, Gaafar KM. Effects of 3 Rodent Beddings on Biochemical Measures in Rats and Mice. J Am Assoc Lab Anim Sci. 2018;57(5):443–446. doi:10.30802/AALAS-JAALAS-18-000023
  • Chen Y, Qu D, Fu R, et al. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment. Int J Nanomedicine. 2018;13:7275–7287. doi:10.2147/IJN.S182475
  • Cheng MB, Wang JC, Li YH, et al. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. J Controlled Release. 2008;129(1):41–48. doi:10.1016/j.jconrel.2008.03.018
  • Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016;7(5):365–383. doi:10.1080/19490976.2016.1218585
  • Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396(10263):1675–1688. doi:10.1016/S0140-6736(20)31548-8
  • Li H, Wang T, Shi C, et al. Inhibition of GALR1 in PFC Alleviates Depressive-Like Behaviors in Postpartum Depression Rat Model by Upregulating CREB-BNDF and 5-HT Levels. Front Psychiatry. 2018;9:588. doi:10.3389/fpsyt.2018.00588
  • Rosa K, Delgado-Herrera L, Zeiher B, et al. Psychometric assessment of the IBS-D Daily Symptom Diary and Symptom Event Log. Quality Res. 2016;25(12):3197–3208. doi:10.1007/s11136-016-1335-1